Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus
Thessalia Papasavva(Cyprus Institute of Neurology and Genetics), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Charis Kontos(Paphos General Hospital), Tobias J. Legler(University of Göttingen), Demetris Papapetrou(American Heart Institute), Tasos Christodoulou(Hippocrateon Private Hospital), Agathoklis Christofides(Archbishop Makarios III Hospital), Petros Kountouris(Cyprus Institute of Neurology and Genetics), Telis Patroclos(Limassol General Hospital), Marios Phylaktou(Hippocrateon Private Hospital), Eleni Pavlou(Cyprus Institute of Neurology and Genetics), C. Ellen van der Schoot(Dutch Blood Transfusion Society), George Anastasiou(American Heart Institute), Barbera Veldhuisen(Sanquin), Prokopis Kerimis(Limassol General Hospital), George Leontiades, Marios Liasides(Limassol General Hospital), Sotos Demetriou, Eleni Karitzie(Cyprus Institute of Neurology and Genetics), Pete Martin(Bristol Institute for Transfusion Sciences), Nikos Zottis
Cited by 14
Related Papers
New gene functions in megakaryopoiesis and platelet formation
|Nature|2011|424
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
|Science|2020|410
Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance
|International Journal of Cancer|1988|273
SMIM1 underlies the Vel blood group and influences red blood cell traits
|Nature Genetics|2013|120